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Abstract: 
Numerous studies have found excessive or in appropriate use of antipsychotic drugs in nursing 
home patients with cognitive impairment or perceived behavioral issues. Inappropriately 
medicating this vulnerable population can lead to several negative outcomes, including failure to 
have needs met, injury, illness, and even death. In response to recent literature and government 
reports highlighting this issue, in 2012, the Centers for Medicare and Medicaid Services (CMS) 
launched an initiative called the National Partnership to Improve Dementia Care. This article 
discusses the CMS initiative, as well as the feasibility and recent trends in the use of 
nonpharmacological interventions that could be implemented when working with patients with 
cognitive impairment and behavioral and psychological symptoms associated with dementia. 
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Article: 
A survey conducted in 2010 by the National Center for Health Statistics found that 
approximately 971,900 individuals in the United States were residing in residential care facilities 
(Caffrey et al., 2012). By 2050, the numbers are expected to rise to 27 million (Caffrey, 
Sengupta, Moss, Harris-Kojetin, & Valverde, 2011). Ninety percent of individuals in the 2010 
survey were 65 and older; 28% were diagnosed with depression, and 42% were diagnosed with 
Alzheimer’s disease and other dementias (Caffrey et al., 2012). People with dementia may have 
difficulty communicating their thoughts and needs to other residents, family members, and staff. 
In many cases, in their efforts to communicate, patients with dementia may exhibit behaviors that 
are misunderstood, and as a result, patients may be labeled as “difficult.” Family, staff, and 
primary care providers (PCPs) may consider pharmacological interventions as simple and quick 
solutions to what they perceive as a problem, although medications may not resolve the real issue 
or address patients’ unmet needs. 
Pharmacological approaches involving inappropriate and unnecessary antipsychotic drugs are 
used in patients with cognitive impairment or perceived behavioral issues as first-line treatment, 
even though clinical trials show only modest evidence of efficacy compared to high placebo 
effects (Ballard & O’Brien, 1999; Douglas, James, & Ballard, 2004; Margallo-Lana et al., 2001). 
A study conducted by the Centers for Medicare and Medicaid Services (CMS, 2010) from July to 
September 2010 found that 39.4% of residents in nursing homes across the nation were given 
antipsychotic drugs despite the fact they were never diagnosed with psychosis. Inappropriately 
medicating this vulnerable population can lead to several negative outcomes, including failure to 
have needs met, injury, illness, and even death. This article discusses the feasibility and recent 
trends in the use of nonpharmacological interventions that could be implemented when working 
with patients with cognitive impairment and behavioral and psychological symptoms associated 
with dementia. 
What Are Nonpharmacological Interventions? 
Nonpharmacological interventions are strategies that are used for the purpose of preventing, 
reducing, or eliminating behavioral and psychological symptoms associated with dementia 
without the use of, or in conjunction with, pharmaceutical agents. These interventions are based 
on the specific needs, preferences, and the functional abilities of the older adult (Cohen-
Mansfield, Libin, & Marx, 2007; Janzen, Zecevic, Kloseck, & Orange, 2013). 
Nonpharmacological interventions fit three broad categories: (a) unmet needs interventions that 
assume the behavior is a form of communicating an underlying need, such as pain reduction or 
sensory stimulation; (b) behavioral interventions that assume the individual’s behavior has been 
inadvertently reinforced (e.g., screaming to get attention); and (c) reduced stress-threshold 
interventions that assume a mismatch between the individual’s abilities to cope and demands of 
the environment (Cohen-Mansfield, 2001; Lawton & Nahemow, 1973). Interventions could be 
seeking underlying causes of the behavior, staff education, modification to the environment, 
providing for a basic unmet need, or having patients engage in a diversional or active 
engagement activity based on their specific profile, with consideration for their behaviors and 
needs. 
Feasibility of Nonpharmacological Interventions 
Historically, the feasibility of using nonpharmacological interventions in residential settings has 
been limited. Resident barriers may include perceived unwillingness to participate, 
unresponsiveness, or sleeping when the intervention is offered. Mealtimes, personal care, and 
medication passes also may impede participation in a nonpharmacological intervention (Cohen-
Mansfield, Thein, Marx, & Dakheel-Ali, 2012). Environmental barriers include lack of a quiet 
space, the activity being bothersome to others, and the room’s temperature or atmosphere (e.g., 
too hot, too cold, too small, noisy) (Cohen-Mansfield et al., 2007). 
The barriers from nursing staff may include inconsistency in staffing, the inability of staff 
members to implement nonpharmacological interventions, and requirements for staff training 
about the interventions (Seitz & Gill, 2013). Poor educational approaches, including repetitive 
information and training in lecture format rather than active learning, may result in disinterest 
and inability to understand how to implement nonpharmacological interventions. Not every staff 
member has access to information about the nonpharmacological interventions in a resident’s 
care plan; therefore, staff may be uninformed (Janzen et al., 2013). 
In a qualitative study of 44 staff in five long-term care facilities, Janzen et al. (2013) identified 
other common barriers to nonpharmacological interventions including perceived lack of time, 
low staff-to-resident ratios, and the perceived unpredictable and short-lasting effectiveness of 
nonpharmacological interventions. The belief by staff that residents with limited functional status 
would not benefit from nonpharmacological interventions was another reason given for not 
attempting these interventions (Cohen-Mansfield et al., 2007). Staff perceptions of agitation; 
inconsistency in assessing, describing, and addressing agitation; and nursing preference for 
medication have been shown to be additional reasons for avoiding nonpharmacological 
interventions. Nursing staff note that medications were used to allow staff to perform activities 
of daily living, such as bathing (Janzen et al., 2013). Nurses also expressed a preference for 
medication use due to the urgent need to deal with behavioral and psychological symptoms, 
particularly when many such behaviors are occurring at the same time. 
In a descriptive study of barriers to intervention implementation, Cohen-Mansfield et al. (2012) 
found that PCPs (N = 89) did not have enough information to make recommendations for 
nonpharmacological interventions, as they lacked training, knowledge, and skills. This caused a 
lack of confidence in recommending nonpharmacological interventions and more comfort in 
writing prescriptions for medications without consideration of the efficacy of 
nonpharmacological intervention use. Seitz and Gill’s (2013) systematic review of the use of 
nonpharmacological interventions noted that many PCPs believed these interventions were too 
time-consuming and too expensive and that motivating the residents was too difficult. In a study 
of 948 family physicians, many providers thought that residents and their families expected them 
to write prescriptions for difficult behavior (Anthierens et al., 2010). 
Cohen-Mansfield et al. (2012) also noted that the feasibility of implementing 
nonpharmacological interventions was limited by family and administrator issues. Families often 
requested a medication be prescribed and cited a fear of injury while participating in a 
nonpharmacological intervention activity. Administrators had little, if any, understanding of 
nonpharmacological interventions; therefore, they often did not wish to invest the time the staff 
required for training and mentoring or did not provide funding for implementation. 
Two systematic reviews concluded that system issues, such as the perception that 
nonpharmacological interventions are too costly, threatened the feasibility of implementing 
nonpharmacological strategies (Knapp, Iemmi, & Romeo, 2013;Seitz & Gill, 2013). Janzen et al. 
(2013) noted a lack of communication between disciplines and a lack of standardized practices in 
this area. Some caregivers felt unable to individualize interventions due to competing job 
responsibilities and high turnover of staff (Clark, 2012). Research on nonpharmacological 
interventions is limited, and the research that has been done was in smaller studies, which do not 
provide the evidence necessary to implement system changes (Clark, 2012; O’Neil et al., 2011). 
CMS Initiative 
In response to a report by the Office of the Inspector General (U.S. Department of Health and 
Human Services, 2011), a group of nursing home consumer advocates met with senior leaders at 
CMS to discuss their concerns about the overuse of antipsychotic drugs in nursing home 
residents with dementia. Leaders from for-profit and not-for-profit nursing home organizations, 
the American Medical Directors Association, the American Society for Consultant Pharmacists, 
several nursing organizations, the national ombudsman program, and others joined forces to form 
the National Partnership to Improve Dementia Care. The overarching goal of the partnership is 
to identify ways to improve dementia care broadly and in all settings. 
Over several months and through numerous telephone outreach calls, state coalitions were 
established in every state, often led by the quality improvement organization (QIO), the state 
local area network for excellence (LANE), or other entities working on quality improvement. In 
all cases, advocates, residents and families, ombudsmen, and others were invited to participate. 
CMS held quarterly conference calls to share best practices and to enable state coalitions to learn 
from each other and integrate their efforts with the fundamental quality improvement work being 
done with the QIOs, LANEs, and in anticipation of the new regulation for Quality Assurance 
Performance Improvement. 
CMS also began publicly reporting data for each nursing home on the Nursing Home Compare 
website in July 2012 (http://www.medicare.gov/nursinghomecompare/search.html). The Nursing 
Home Compare website has recently been redesigned with substantial input from consumers. 
The new website provides additional information about the use of antipsychotic medications for 
dementia to assist consumers who may be trying to choose a nursing home for a loved one. 
With input from national experts and dementia care practitioners, CMS also revised the surveyor 
guidance at F309 Care and Services for a Resident with Dementia and F329 Unnecessary Drugs. 
The updated guidance provides more detailed information about state-of-the-art dementia 
practices; the involvement of residents, families, and direct care workers in dementia care plan 
development and implementation; and ways to evaluate the use of antipsychotic medications in 
cases where they are used for residents with dementia. The programs stress the critical role of 
direct care workers (e.g., certified nursing assistants [CNAs]) and the importance of obtaining 
input from the family about patients’ previous routines and life preferences. Three training 
programs are currently available on the surveyor training website; they are open access and may 
be viewed by providers and the public 
(http://surveyortraining.cms.hhs.gov/pubs/AntiPsychoticMedHome.aspx). 
Several national organizations have contacted their members via e-mail or sent letters providing 
information on the initiative and encouraging engagement in review of any residents with 
dementia on an antipsychotic medication for potential gradual dose reduction (GDR). Tools and 
resources to support potential GDRs are available on the Advancing Excellence in America’s 
Nursing Homes website (http://www.nhqualitycampaign.org). Numerous educational programs 
for providers and prescribers have been held throughout the country, and many webinars have 
been archived and remain available. 
Nursing Implications For The Use Of Nonpharmacological Interventions 
To better control or regulate the use of nonpharmacological interventions, there are expectations 
of staff and facilities when using nonpharmacological interventions with their residents. Based 
on the new guidance and training, surveyors will be evaluating processes and outcomes such as 
consistent CNA assignments to provide patient-centered care. CNAs play a critical role in 
detecting actual or potential manifestations of dementia and reporting them to nursing 
supervisors. Therefore, surveyors will be looking for CNA involvement in using 
nonpharmacological interventions to address residents’ needs. Nurses should make certain that 
CNAs attend care planning meetings whenever possible, to ensure multidisciplinary involvement 
as well as provide key information for planning care. It is also vital that CNAs are aware of all 
the goals for the residents under their care. Participation in these meetings and in ongoing 
dialogue with the team will provide CNAs with the information they need. Family members 
should be asked for any input or recommendations to help staff understand the reasons for a 
particular behavior that does not respond to initial nonpharmacological interventions. 
Providing nonpharmacological interventions for behaviors in individuals with dementia is the 
responsibility of all departments and all staff members. Physicians and nurse practitioners are 
being encouraged to consider recommending non-pharmacological interventions prior to 
considering medication. More detailed needs assessments reflecting individualized needs and 
preferences will help staff better facilitate nonpharmacological interventions with older adults. 
Nurses should therefore be performing environmental, basic needs, and physical assessments to 
determine the potential underlying causes when there is a behavior change. Specific charting on 
behaviors, the nonpharmacological interventions attempted, and the specific outcomes can be 
used to make future behavioral interventions more effective for residents. A change in behaviors 
is often the first sign of an acute medical condition. Identifying medical causes such as infections 
or delirium should be ruled out. For the individual with dementia, behavioral symptoms may be 
the only means of communicating a change in condition or illness, unmet needs, or person–
environment incompatibility. 
Summary 
Nonpharmacological interventions must be better integrated into individualized care in all 
nursing homes to achieve the goals of the CMS initiative. Although progress is being made, 
more work needs to be done. Studies have consistently reported that a lack of essential 
information about nonpharmacological interventions is a substantial yet remediable problem 
(Hoffmann, Erueti, & Glasziou, 2013). Research articles discussing statistics on the use of 
nonpharmacological interventions are available, but essential details about selecting and 
implementing a nonpharmacological intervention are seldom provided. More systematic research 
is needed to identify the benefits of specific nonpharmacological interventions for specific 
behaviors. The next three articles in this series will provide guidelines on implementation of 20 
nonpharmacological interventions that are feasible for caregivers to perform. The second article 
will discuss the essential skills and knowledge necessary to perform these interventions; articles 
three and four will address the specific interventions with protocols and the best evidence for 
their effectiveness. 
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